Annual Non Current Assets
$12.37 M
-$31.91 M-72.06%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual long term assets is $12.37 million, with the most recent change of -$31.91 million (-72.06%) on December 31, 2023.
- During the last 3 years, ABUS annual non current assets has risen by +$3.00 million (+31.98%).
- ABUS annual non current assets is now -97.66% below its all-time high of $528.41 million, reached on December 31, 2015.
Performance
ABUS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$7.66 M
-$4.16 M-35.18%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly long term assets is $7.66 million, with the most recent change of -$4.16 million (-35.18%) on September 30, 2024.
- Over the past year, ABUS quarterly non current assets has dropped by -$6.75 million (-46.84%).
- ABUS quarterly non current assets is now -98.63% below its all-time high of $558.12 million, reached on June 30, 2015.
Performance
ABUS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ABUS Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.1% | -46.8% |
| 3 y3 years | +32.0% | -82.7% |
| 5 y5 years | -87.5% | -82.7% |
ABUS Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.1% | at low | -88.1% | at low |
| 5 y | 5-year | -72.1% | +32.0% | -88.1% | at low |
| alltime | all time | -97.7% | +2376.3% | -98.6% | +532.3% |
Arbutus Biopharma Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.66 M(-35.2%) |
| Jun 2024 | - | $11.82 M(-18.0%) |
| Mar 2024 | - | $14.42 M(+16.5%) |
| Dec 2023 | $132.03 M(-12.6%) | $12.37 M(-27.4%) |
| Sep 2023 | - | $17.03 M(-5.5%) |
| Jun 2023 | - | $18.02 M(-53.0%) |
| Mar 2023 | - | $38.37 M(-13.3%) |
| Dec 2022 | $151.14 M(-5.9%) | $44.28 M(-29.3%) |
| Sep 2022 | - | $62.66 M(+8.0%) |
| Jun 2022 | - | $58.05 M(-9.6%) |
| Mar 2022 | - | $64.18 M(+46.4%) |
| Dec 2021 | $160.66 M(+25.8%) | $43.82 M(+12.2%) |
| Sep 2021 | - | $39.06 M(-24.8%) |
| Jun 2021 | - | $51.91 M(+483.3%) |
| Mar 2021 | - | $8.90 M(-5.1%) |
| Dec 2020 | $127.70 M(+36.1%) | $9.38 M(-4.9%) |
| Sep 2020 | - | $9.86 M(-18.4%) |
| Jun 2020 | - | $12.09 M(-15.3%) |
| Mar 2020 | - | $14.28 M(+22.0%) |
| Dec 2019 | $93.83 M(-27.4%) | $11.71 M(-49.0%) |
| Sep 2019 | - | $22.94 M(-75.3%) |
| Jun 2019 | - | $92.99 M(-3.9%) |
| Mar 2019 | - | $96.73 M(-2.0%) |
| Dec 2018 | $129.23 M(-0.1%) | $98.68 M(-2.7%) |
| Sep 2018 | - | $101.39 M(-15.0%) |
| Jun 2018 | - | $119.25 M(+25.7%) |
| Mar 2018 | - | $94.84 M(-12.0%) |
| Dec 2017 | $129.37 M(-2.4%) | $107.80 M(-27.7%) |
| Sep 2017 | - | $149.03 M(-0.1%) |
| Jun 2017 | - | $149.15 M(+0.9%) |
| Mar 2017 | - | $147.87 M(+3.2%) |
| Dec 2016 | $132.56 M(-27.9%) | $143.35 M(-60.5%) |
| Sep 2016 | - | $362.92 M(+0.0%) |
| Jun 2016 | - | $362.78 M(-31.4%) |
| Mar 2016 | - | $528.50 M(+0.0%) |
| Dec 2015 | $183.88 M(+57.9%) | $528.41 M(+1.1%) |
| Sep 2015 | - | $522.60 M(-6.4%) |
| Jun 2015 | - | $558.12 M(+2.0%) |
| Mar 2015 | - | $547.29 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $116.42 M(+65.5%) | $1.76 M(-86.8%) |
| Sep 2014 | - | $13.32 M(-4.2%) |
| Jun 2014 | - | $13.90 M(+814.1%) |
| Mar 2014 | - | $1.52 M(+10.8%) |
| Dec 2013 | $70.34 M(+37.3%) | $1.37 M(+0.4%) |
| Sep 2013 | - | $1.37 M(-0.1%) |
| Jun 2013 | - | $1.37 M(+0.9%) |
| Mar 2013 | - | $1.36 M(+0.4%) |
| Dec 2012 | $51.24 M(+343.6%) | $1.35 M(-12.8%) |
| Sep 2012 | - | $1.55 M(-9.5%) |
| Jun 2012 | - | $1.71 M(-12.6%) |
| Mar 2012 | - | $1.96 M(-8.8%) |
| Dec 2011 | $11.55 M(-35.5%) | $2.15 M(-8.4%) |
| Sep 2011 | - | $2.35 M(-15.5%) |
| Jun 2011 | - | $2.78 M(-7.8%) |
| Mar 2011 | - | $3.01 M(-3.2%) |
| Dec 2010 | $17.91 M(-27.8%) | $3.11 M(-81.4%) |
| Sep 2010 | - | $16.69 M(-0.3%) |
| Jun 2010 | - | $16.74 M(-5.3%) |
| Mar 2010 | - | $17.68 M(+457.5%) |
| Dec 2009 | $24.79 M(-9.3%) | $3.17 M(-81.0%) |
| Sep 2009 | - | $16.73 M(+7.0%) |
| Jun 2009 | - | $15.64 M(+6.3%) |
| Mar 2009 | - | $14.71 M(-2.0%) |
| Dec 2008 | $27.33 M(+17.3%) | $15.01 M(-13.2%) |
| Sep 2008 | - | $17.29 M(-21.6%) |
| Jun 2008 | - | $22.06 M(+1117.7%) |
| Mar 2008 | - | $1.81 M(+17.6%) |
| Dec 2007 | $23.29 M(+320.9%) | $1.54 M(+10.9%) |
| Sep 2007 | - | $1.39 M(+14.6%) |
| Jun 2007 | - | $1.21 M |
| Dec 2006 | $5.53 M(-49.3%) | - |
| Dec 2005 | $10.92 M(-62.0%) | - |
| Dec 2004 | $28.73 M(-28.3%) | - |
| Dec 2003 | $40.10 M(-19.5%) | - |
| Dec 2001 | $49.78 M(+97.3%) | - |
| Dec 2000 | $25.23 M(+24.8%) | - |
| Dec 1999 | $20.22 M(+196.5%) | - |
| Dec 1998 | $6.82 M | - |
FAQ
- What is Arbutus Biopharma annual long term assets?
- What is the all time high annual non current assets for Arbutus Biopharma?
- What is Arbutus Biopharma annual non current assets year-on-year change?
- What is Arbutus Biopharma quarterly long term assets?
- What is the all time high quarterly non current assets for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly non current assets year-on-year change?
What is Arbutus Biopharma annual long term assets?
The current annual non current assets of ABUS is $12.37 M
What is the all time high annual non current assets for Arbutus Biopharma?
Arbutus Biopharma all-time high annual long term assets is $528.41 M
What is Arbutus Biopharma annual non current assets year-on-year change?
Over the past year, ABUS annual long term assets has changed by -$31.91 M (-72.06%)
What is Arbutus Biopharma quarterly long term assets?
The current quarterly non current assets of ABUS is $7.66 M
What is the all time high quarterly non current assets for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly long term assets is $558.12 M
What is Arbutus Biopharma quarterly non current assets year-on-year change?
Over the past year, ABUS quarterly long term assets has changed by -$6.75 M (-46.84%)